Chaofeng Ding

1.4k citations

26 papers · 1.1k indexed · h-index 18

Impact in

Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
- Histone Deacetylase Inhibitors Research

Papers in ⓘ

Cancer Research 12
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 4
- Cancer, Hypoxia, and Metabolism 4
- Cancer, Lipids, and Metabolism 2
Molecular Biology 19
- RNA modifications and cancer 4
- Circular RNAs in diseases 3
- Ubiquitin and proteasome pathways 3

Co-authors: Shusen Zheng (22 shared papers)Jian Wu (20 shared papers)Haiyang Xie (17 shared papers)Zhen Lv (16 shared papers)Chengli Du (12 shared papers)Chuanhui Peng (11 shared papers)Shaobing Cheng (12 shared papers)Heng Xiao (9 shared papers)
Journals: International Journal of Molecular Sciences (2 papers)Cancer Letters (2 papers)Oncotarget (2 papers)Molecular Carcinogenesis (1 paper)Scientific Reports (1 paper)
Partner nations: China Madagascar

In The Last Decade

Chaofeng Ding

24 papers receiving 1.0k citations

Peers

Countries citing papers authored by Chaofeng Ding

Since Specialization

Citations

This map shows the geographic impact of Chaofeng Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chaofeng Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chaofeng Ding more than expected).

Fields of papers citing papers by Chaofeng Ding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chaofeng Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chaofeng Ding. The network helps show where Chaofeng Ding may publish in the future.

Co-authors

The 25 scholars most cited alongside Chaofeng Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chaofeng Ding Line = papers co-authored together Chaofeng Ding links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway Cancer Letters ·Junru Chen, Chaofeng Ding, Yunhao Chen, Wendi Hu, Chengkuan Yu, Chuanhui Peng, Xiaode Feng, Qiyang Cheng, Wenxuan Wu, Yuejie Lu, Haiyang Xie, Lin Zhou, Jian Wu, Shusen Zheng	2020	162
2	Long Non-Coding RNA HOTAIR Promotes Cell Migration and Invasion via Down-Regulation of RNA Binding Motif Protein 38 in Hepatocellular Carcinoma Cells International Journal of Molecular Sciences ·Chaofeng Ding, Shaobing Cheng, Zhe Yang, Zhen Lv, Heng Xiao, Chengli Du, Chuanhui Peng, Haiyang Xie, Lin Zhou, Jian Wu, Shusen Zheng	2014	140
3	Long non-coding RNA PVT1 is associated with tumor progression and predicts recurrence in hepatocellular carcinoma patients Oncology Letters ·Chaofeng Ding, Zhe Yang, Zhen Lv, Chengli Du, Heng Xiao, Chuanhui Peng, Shaobing Cheng, Haiyang Xie, Lin Zhou, Jian Wu, Shusen Zheng	2014	110
4	MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2 Journal of Translational Medicine ·Chengli Du, Zhen Lv, Linping Cao, Chaofeng Ding, Kwabena Gyabaah Owusu-Ansah, Haiyang Xie, Lin Zhou, Jian Wu, Shusen Zheng	2014	100
5	The Up-Regulation of Histone Deacetylase 8 Promotes Proliferation and Inhibits Apoptosis in Hepatocellular Carcinoma Digestive Diseases and Sciences ·Jian Wu, Chengli Du, Zhen Lv, Chaofeng Ding, Junhao Cheng, Haiyang Xie, Lin Zhou, Shusen Zheng	2013	86
6	ACSL4 promotes hepatocellular carcinoma progression via c-Myc stability mediated by ERK/FBW7/c-Myc axis Oncogenesis ·Junru Chen, Chaofeng Ding, Yunhao Chen, Wendi Hu, Yuejie Lu, Wenxuan Wu, Yanpeng Zhang, Beng Yang, Hao Wu, Chuanhui Peng, Haiyang Xie, Lin Zhou, Jian Wu, Shusen Zheng	2020	71
7	Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma Journal of Experimental & Clinical Cancer Research ·Chengli Du, Xiaoyu Weng, Wendi Hu, Zhen Lv, Heng Xiao, Chaofeng Ding, Owusu-anash K. Gyabaah, Haiyang Xie, Lin Zhou, Jian Wu, Shusen Zheng	2015	61
8	BAG3 regulates epithelial–mesenchymal transition and angiogenesis in human hepatocellular carcinoma Laboratory Investigation ·Heng Xiao, Shaobing Cheng, Rongliang Tong, Zheng Lv, Chaofeng Ding, Chengli Du, Haiyang Xie, Lin Zhou, Jian Wu, Shusen Zheng	2013	41
9	Downregulation of HDAC6 promotes angiogenesis in hepatocellular carcinoma cells and predicts poor prognosis in liver transplantation patients Molecular Carcinogenesis ·Zhen Lv, Xiaoyu Weng, Chengli Du, Cheng Zhang, Heng Xiao, Xianlei Cai, Sunyi Ye, Junhao Cheng, Chaofeng Ding, Haiyang Xie, Lin Zhou, Jian Wu, Shusen Zheng	2015	39
10	γ-H2AX promotes hepatocellular carcinoma angiogenesis via EGFR/HIF-1α/VEGF pathways under hypoxic condition Oncotarget ·Heng Xiao, Rongliang Tong, Chaofeng Ding, Zhen Lv, Chengli Du, Chuanhui Peng, Shaobing Cheng, Haiyang Xie, Lin Zhou, Jian Wu, Shusen Zheng	2014	34
11	Over Expression of Long Non-Coding RNA PANDA Promotes Hepatocellular Carcinoma by Inhibiting Senescence Associated Inflammatory Factor IL8 Scientific Reports ·Chuanhui Peng, Wendi Hu, Xiaoyu Weng, Rongliang Tong, Shaobing Cheng, Chaofeng Ding, Heng Xiao, Zhen Lv, Haiyang Xie, Lin Zhou, Jian Wu, Shusen Zheng	2017	28
12	Expression and Critical Role of Interleukin Enhancer Binding Factor 2 in Hepatocellular Carcinoma International Journal of Molecular Sciences ·Shaobing Cheng, Xu Jiang, Chaofeng Ding, Chengli Du, Kwabena Gyabaah Owusu-Ansah, Xiaoyu Weng, Wendi Hu, Chuanhui Peng, Zhen Lv, Rongliang Tong, Heng Xiao, Haiyang Xie, Lin Zhou, Jian Wu, Shusen Zheng	2016	28
13	Targeting Mybbp1a suppresses HCC progression via inhibiting IGF1/AKT pathway by CpG islands hypo-methylation dependent promotion of IGFBP5 EBioMedicine ·Xiaoyu Weng, Jingbang Wu, Zhen Lv, Chuanhui Peng, Junru Chen, Cheng Zhang, Bin He, Rongliang Tong, Wendi Hu, Chaofeng Ding, Linping Cao, Diyu Chen, Jian Wu, Shusen Zheng	2019	24
14	Downregulation of Peptidylprolyl isomerase A promotes cell death and enhances doxorubicin-induced apoptosis in hepatocellular carcinoma Gene ·Shaobing Cheng, Mengchao Luo, Chaofeng Ding, Chuanhui Peng, Zhen Lv, Rongliang Tong, Heng Xiao, Haiyang Xie, Lin Zhou, Jian Wu, Shusen Zheng	2016	24
15	TAZ regulates cell proliferation and sensitivity to vitamin D3 in intrahepatic cholangiocarcinoma Cancer Letters ·Heng Xiao, Rongliang Tong, Beng Yang, Zhen Lv, Chengli Du, Chuanhui Peng, Chaofeng Ding, Shaobing Cheng, Lin Zhou, Haiyang Xie, Jian Wu, Shusen Zheng	2016	24
16	H2A.Z regulates tumorigenesis, metastasis and sensitivity to cisplatin in intrahepatic cholangiocarcinoma International Journal of Oncology ·Beng Yang, Rongliang Tong, Hua Liu, Jingbang Wu, Diyu Chen, Zhengze Xue, Chaofeng Ding, Lin Zhou, Haiyang Xie, Jian Wu, Shusen Zheng	2018	21
17	Identification of bile biomarkers of biliary tract cancer through a liquid chromatography/mass spectrometry-based metabolomic method Molecular Medicine Reports ·Xiaofeng Xu, Shaobing Cheng, Chaofeng Ding, Zhen Lv, Deying Chen, Jian Wu, Shusen Zheng	2014	18
18	BAG3 and HIF-1αCoexpression Detected by Immunohistochemistry Correlated with Prognosis in Hepatocellular Carcinoma after Liver Transplantation BioMed Research International ·Heng Xiao, Rongliang Tong, Shaobing Cheng, Zhen Lv, Chaofeng Ding, Chengli Du, Haiyang Xie, Lin Zhou, Jian Wu, Shusen Zheng	2014	17
19	KCTD11 inhibits growth and metastasis of hepatocellular carcinoma through activating Hippo signaling Oncotarget ·Rongliang Tong, Beng Yang, Heng Xiao, Chuanhui Peng, Wendi Hu, Xiaoyu Weng, Shaobing Cheng, Chengli Du, Zhen Lv, Chaofeng Ding, Lin Zhou, Haiyang Xie, Jian Wu, Shusen Zheng	2017	17
20	Long Noncoding RNA PVT1 Is Associated with Tumor Progression and Predicts Recurrence in Hepatocellular Carcinoma Patients Journal of the American College of Surgeons ·Chaofeng Ding, Zhe Yang, Shaobing Cheng, Jian Wu, Shusen Zheng	2014	10

About Chaofeng Ding

Chaofeng Ding is a scholar working on Cancer Research, Molecular Biology, Hepatology, Oncology and Cell Biology, having authored 26 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), MicroRNA in disease regulation (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), RNA modifications and cancer (4 papers), Circular RNAs in diseases (3 papers), Ubiquitin and proteasome pathways (3 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (645 citations), Molecular Biology (833 citations), Oncology (143 citations), Hepatology (32 citations) and Biochemistry (28 citations). Chaofeng Ding has collaborated with scholars based in China and Madagascar. Frequent co-authors include Shusen Zheng, Jian Wu, Haiyang Xie, Zhen Lv, Chengli Du, Chuanhui Peng, Shaobing Cheng, Heng Xiao, Lin Zhou and Lin Zhou. Their work appears in journals such as International Journal of Molecular Sciences, Cancer Letters, Oncotarget, Molecular Carcinogenesis and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact